Related Experiment Videos
What does the BJD now stand for? A position statement
1Betsi Cadwaladr University Health Board, Ysbyty Gwynedd, Penrhosgarnedd, Bangor, Gwynedd, LL57 2PY, U.K.
The British Journal of Dermatology
|June 4, 2015
Summary
No abstract available in PubMed .
Related Concept Videos
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Baseline characteristics of atopic eczema patients enrolled in seven European registries united in the TREatment of ATopic eczema (TREAT) registry taskforce.
Journal of the European Academy of Dermatology and Venereology : JEADV·2025
Same author
Anakinra for palmoplantar pustulosis: results from a randomized, double-blind, multicentre, two-staged, adaptive placebo-controlled trial (APRICOT).
The British journal of dermatology·2021
Same author
The use of psoriasis biomarkers, including trajectory of clinical response, to predict clearance and remission duration to UVB phototherapy.
Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author
Risks of basal cell and squamous cell carcinoma in psoriasis patients after treatment with biologic vs non-biologic systemic therapies.
Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author
Defining trajectories of response in patients with psoriasis treated with biologic therapies.
The British journal of dermatology·2021
Same author
Characteristics and skin cancer risk of psoriasis patients with a history of skin cancer in BADBIR.
Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same journal
Does loss of chromosome Y in blood contribute to the sex disparity of dermatitis and eczema at older ages?
The British journal of dermatology·2026
Same journal
Soluble CD83 reverses alopecia areata via IDO-mediated Treg cell activation.
The British journal of dermatology·2026
Same journal
Durability of Response to Icotrokinra in Adults With Moderate-to-Severe Plaque Psoriasis: One-Year Results From the Phase 3, Placebo- and Active Comparator-Controlled ICONIC-ADVANCE 1 & ICONIC-ADVANCE 2 Trials.
The British journal of dermatology·2026
Same journal
Clinicopathological features of lymphocytic thrombophilic arteritis and the relationship with livedoid vasculopathy - a case series of 36 patients.
The British journal of dermatology·2026
Same journal
Improving Prognostication for Cutaneous Squamous Cell Carcinoma.
The British journal of dermatology·2026
Same journal
Recurrent and novel GLTP variants in five patients with nonsyndromic epidermal differentiation disorder: phenotypic and genotypic expansion.
The British journal of dermatology·2026